These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18623939)

  • 21. Analysis of the effect of age on the prognosis of breast cancer.
    Cluze C; Colonna M; Remontet L; Poncet F; Sellier E; Seigneurin A; Delafosse P; Bossard N
    Breast Cancer Res Treat; 2009 Sep; 117(1):121-9. PubMed ID: 18931908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
    Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DEGRO practical guidelines for radiotherapy of breast cancer II. Postmastectomy radiotherapy, irradiation of regional lymphatics, and treatment of locally advanced disease.
    Sautter-Bihl ML; Souchon R; Budach W; Sedlmayer F; Feyer P; Harms W; Haase W; Dunst J; Wenz F; Sauer R
    Strahlenther Onkol; 2008 Jul; 184(7):347-53. PubMed ID: 19016032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time to disease recurrence in basal-type breast cancers: effects of tumor size and lymph node status.
    Dent R; Hanna WM; Trudeau M; Rawlinson E; Sun P; Narod SA
    Cancer; 2009 Nov; 115(21):4917-23. PubMed ID: 19691094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
    Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The evolution of lymph node assessment in breast cancer.
    Quan ML; McCready D
    J Surg Oncol; 2009 Mar; 99(4):194-8. PubMed ID: 19021226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?
    Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N
    Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Problems in clinical assessment of palatal tumours.
    Cousins VC
    Aust N Z J Surg; 1986 Feb; 56(2):109-12. PubMed ID: 3460543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast cancer: cured or not?
    Harris JC
    J Insur Med; 1997; 29(4):263-9. PubMed ID: 10181166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic resonance imaging for axillary staging in patients with breast cancer.
    Mortellaro VE; Marshall J; Singer L; Hochwald SN; Chang M; Copeland EM; Grobmyer SR
    J Magn Reson Imaging; 2009 Aug; 30(2):309-12. PubMed ID: 19466713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognostic role of telethermography in breast cancer].
    Mustacchi G; Monti GF; Pietri P; Ciatto S; Sasso F
    Minerva Chir; 1987 Oct; 42(20):1631-4. PubMed ID: 3683925
    [No Abstract]   [Full Text] [Related]  

  • 32. Sensitivity to input variability of the Adjuvant! Online breast cancer prognostic model.
    Ozanne EM; Braithwaite D; Sepucha K; Moore D; Esserman L; Belkora J
    J Clin Oncol; 2009 Jan; 27(2):214-9. PubMed ID: 19047286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
    Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
    Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for late relapse and death in patients with early breast cancer.
    Grasic-Kuhar C; Bracko M; Zakotnik B
    Neoplasma; 2008; 55(5):416-20. PubMed ID: 18665752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors for survival in breast cancer patients who developed distant metastasis subsequent to definitive surgery.
    Kuru B; Camlibel M; Dinc S; Gulcelik MA; Gonullu D; Alagol H
    Singapore Med J; 2008 Nov; 49(11):904-11. PubMed ID: 19037557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of breast MRI in clinical practice.
    Brennan M; Spillane A; Houssami N
    Aust Fam Physician; 2009 Jul; 38(7):513-9. PubMed ID: 19575070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimates of clinically useful measures in competing risks survival analysis.
    Ambrogi F; Biganzoli E; Boracchi P
    Stat Med; 2008 Dec; 27(30):6407-25. PubMed ID: 18937229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rethinking TNM: a breast cancer classification to guide to treatment and facilitate research.
    Veronesi U; Zurrida S; Viale G; Galimberti V; Arnone P; Nolè F
    Breast J; 2009; 15(3):291-5. PubMed ID: 19645785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary angiosarcoma of the breast: clinicopathologic analysis of 49 cases, suggesting that grade is not prognostic.
    Nascimento AF; Raut CP; Fletcher CD
    Am J Surg Pathol; 2008 Dec; 32(12):1896-904. PubMed ID: 18813119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Various prognostic factors in breast cancer].
    Christophersen IS; Sveinsson T; Rygård J
    Ugeskr Laeger; 1977 Jun; 139(23):1356-9. PubMed ID: 878030
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.